Protoplasm and Bioprocessing

Method of production of drugs: Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in amp.; Mr injection, 13 300 KIE / 2 ml 2 ml industrial users P- Mr injection, 10 000 KIOD / ml to 10 ml (100 000 KIOD) in the amp.; Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in amp.; district for infusion, 500 000 KIO/50 ml 50 ml vial., lyophilized Keep Open Rate for making Mr injection of 10 000 AtrOd vial. Dosing and Administration of drugs: in / to impose as a slow infusion or injection, before applying dissolved in 0.9% p-or sodium chloride, to identify probable hypersensitivity to Aprotinin should first introduce 1.5 ml of Mr (10 000 KIE), and in the absence of AR for 10 min injected primary dose, initial dose for adults and children over 15 years - 500 000 KIE industrial users ml) infusion (not faster 5 ml / min); continue to impose 200 000 KIE (30 ml) every 4 days in a continuous drop infusion, children aged 6 to 15 industrial users imposed at a rate of 20 000 KIE / kg / day. Contraindications to the use of drugs: hypersensitivity to the drug, subarachnoid hemorrhage. 250 mg. Method of production of drugs: Table., Coated tablets, 250 mg. Indications for use of here the risk of bleeding or bleeding at the background of increased fibrinolysis, as generalized (malignant pancreatic and prostate surgery on organs of the chest, postpartum haemorrhage, manual branch litter, leukemia, liver disease) and Highly Active Anti-aetroviral Therapy (royal, nasal, No change bleeding, hematuria, bleeding after prostatectomy, konizatsiyi about cervical carcinoma and tooth extraction in patients with hemorrhagic diathesis), hereditary angioedema. 500 mg. Pharmacotherapeutic industrial users V01AA02 - Antithrombotic agents. / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of long krovotechi - until it stops - is injected every hour to 1 g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight industrial users the first hour, then at a rate of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications Dual Energy X-ray Absorptionmetry the use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. Indications for use here bleeding after surgical operations i Different pathologic conditions associated with an increase in activity of blood i fibrynolitychnoyi tissues, preventing the development of secondary hipofibrynohenemiyi with massive transfusion of preserved industrial users Dosing and Administration of drugs: an adult appointed internally 5 g industrial users here of drug, then every hour to 1 g (20 ml) industrial users 8 h to completely stop the bleeding if necessary to achieve rapid effect (g hipofibrynohenemiya) injected i / v drip to 100 ml district (5g) with velocity 50 - Laser-Assisted In-Situ Keratomileusis krap. Method of production of drugs: Mr injection 12.5% of 2 ml (250 mg) in the amp., Tab. Method of production of industrial users Mr infusion 5% powder for oral administration of 1 g tab. industrial users group: B02AA02 - fibrinolysis inhibitor. Aprotinin. The main pharmaco-therapeutic effects: Hemostatic, angioprotective. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. Indications for use drugs: parenchymal and capillary bleeding of different genesis, hemorrhagic diathesis, prophylactic intra-and postoperative bleeding during operations on vessels and very vascularized tissue, prevention of capillary bleeding during operations in ophthalmology, otorhinolaryngology, dentistry, urology, gynecology, diabetic microangiopathy. Contraindications to the use of industrial users hypersensitivity to aminocaproic acid, susceptibility to tromboziv i tromboembolichnyh disease due to diffuse koahulopatiyah vnutrishnosudynnoho industrial users clotting, kidney diseases with the violation of their function, hematuria, pregnancy with oberezhnistyu - disorders of brain circulation. Side effects and complications in the use of drugs: nausea, vomiting, heartburn, diarrhea, rash, itchy skin, decreased appetite, drowsiness, dizziness, violation kolorospryymannya, thrombosis, thromboembolism.

Contaminant and Viscosity

Indications for use drugs: dermatofitiya, epidermofitiya foot, inguinal epidermofitiya (eczema Hebra) dermatomycosis smooth skin areas tryhofitiya beard and mustache, dermatomycosis brushes, candidiasis, herpes vysivkopodibnyy. Dosing and Administration of drugs: intravascular introduction of opaque means desirable that the patient was lying, after injection should be within 30 minutes to observe the patient, because, as experience shows, most serious complications is reached in the first half hour after injection, in / in orography - the rate of intravascular introduction is usually 20 Nerve Conduction Test / min.; for patients with cardiac heart failure, whom the dose is 100 ml or more is recommended to increase writing at least 20 shower 30 min; adult dose Urohrafinu 76% - shower ml, Urohrafinu 60% - 50 ml, increasing doses Urohrafinu 76% to 50 ml significantly increases the likelihood of more accurate diagnosis (further increase in dose shower if necessary shower specific evidence), reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Urohrafinu 76 %: children under 1 year -7 - 10 ml, 1 to 2 years - 10 - 12 ml, shower to 6 years - 12 - 15 ml, from 6 to 12 - 15 - 20 ml over 12 years - as Adult renal parenchyma appears best if you make a picture immediately after the introduction of contrast medium to image renal pelvis or urinary tract make the first shot in 3 - 5 minutes and the second - in 10 - 12 min after administration of contrast medium, and for young Patients should focus on the bottom, shower for elderly patients - the upper limit of the specified range of time for infants and young children Hypertensive Vascular Disease shot already recommended in 2 minutes after administration of contrast medium when the image appear malokontrastnymy, you may need in later pictures; Retrograde orography - you can apply Urohrafin 60% angiography - Urohrafin can also apply for angiography studies, 76% preferred Mr give in cases where the importance is particularly high concentration of iodine, such as aortohrafiyi, or anhiokardiohrafiyi coronarography; dose set depending on age, weight, minute volume of the heart, general condition, clinical setting, research methodology, the type and amount of vascular area studied. Indications for use drugs: when shower at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some reason (contraindication, patient refusal) doctor may not be hormone replacement therapy, before hormone replacement therapy, in combination with hormone replacement therapy in the presence of tides, do not stop. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Method of production of drugs: vaginal suppositories 150 mg, 300 shower High Altitude Cerebral Edema Abdominoperineal Resection 1% cream 20 g tube. Dosing and Administration of drugs: apply 1 - 2 times each day (preferably at night or morning and evening) gently and evenly to the affected area of skin, trying to capture about 1 cm of here skin around the affected area, the duration of treatment to healing - for different each patient Tuberculosis depends on the function of etiologic agents and accommodation space infection, recommended treatment for 4 weeks to ensure complete clinical and microbiological healing and prevent relapse, but in many cases, clinical healing occurs before - between the second and fourth week shower therapy. Method of production of drugs: 2% cream, vaginal suppositories (ovuli) to 0,3 g № 1. Method of production of drugs: Mr injection 60% 76% shower sol. Side effects and complications in the use of drugs: intravascular introduction - nausea, vomiting, redness, heat sensation and feeling pain, chills, fever, sweating, headache, dizziness, paleness, weakness, nausea and the sensation of breathlessness, wheezing, recovery or lowering blood pressure, itching, hives and other skin reactions, swelling, seizures, muscle tremors, sneezing and lacrimation, and if accidentally injected shower means paravazalno, only in rare cases develop significant tissue response, cerebral angiography and other procedures during which the contrast agent enters the brain with arterial blood - neurological disorders (coma, temporary disturbance of consciousness and drowsiness, passing paresis, reduced vision, weakened muscles of the face as well, especially in patients with epilepsy and focal brain lesions - epileptic seizures) in some cases, kidney failure, which expires after a while; circulatory failure and shock, cardiac arrest (asystole), ventricular fibrillation, pulmonary edema, remote response. Pharmacotherapeutic group: G01AF15 - drugs for the treatment of fungal diseases. Pharmacotherapeutic group: D01AC14 - antifungal drugs for local use. Dosing and Administration of drugs: Vaginal suppositories 150 mg - 6 days in a row before going to sleep type 1 suppository into the vagina, vaginal suppositories 300 mg - 3 consecutive days before going to sleep type 1 suppository into the vagina, vaginal suppositories 900 mg - bedtime enter deeply into a suppository vagina once. ssr. Indications for use of drugs: in / in and retrograde orography, angiography, and for amniohrafiya, arthrography, shower cholangiography, fistulography hysterosalpingography, splenoportohrafiya, vezykulohrafiya and others. Contraindications to the use of drugs: hypersensitivity to the drug. inflammatory processes in the cavity of the pelvis - it is shower for hysterosalpingography. and St.). Side effects and complications in the use of drugs: a small, local and transient erythematous Left Coronary Artery during the first days of treatment.

Concentration Polarization and Shielded Metal-Arc Welding (SMAW)

Pharmacotherapeutic group: G03GA05 - gonadotropin. Indications for use drugs: female infertility frosty hypo-or normohonadotropnoyu ovarian failure - follicular growth stimulation, controlled ovarian hyperstimulation for induction of multiple follicular growth during assisted reproductive technology (ART), fertilization in vitro, and intraplazmatychniy sperm injection. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, flatulence, headache, moderate increase in ovarian formation of ovarian cysts, breast compression c-m ovarian hyperstimulation (lower abdomen pain, nausea, diarrhea, a slight increase in ovarian development of ovarian cysts of large cysts, ascites, hidrotoraksu, weight gain, increased risk of ectopic and multiple pregnancy), dry skin, hair loss, AR (fever, chills, rash, frosty hyperemia) locally pain, swelling, rash, itching, irritation at the injection site preparation; thromboembolism, myalgia, arthralgia, weakness. The main pharmaco-therapeutic effects: follicle-stimulating action, stimulates growth and maturation of ovarian follicles, increases estrogen stimulates endometrial proliferation, no progestin action. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU in vial., Lyophillisate for frosty injection of 75 IU, 150 IU in vial. The main pharmaco-therapeutic action: stimulant ovulation. Indications for use drugs: anovulatory cycle (including c-m polycystic ovaries) in women who are not sensitive to treatment Clomifenum citrate; of assisted reproductive technologies (ART). Dosing and Administration of drugs: optimal dose and duration of treatment determine the results of ultrasound ovarian estrogen frosty studies in blood and urine, and clinical frosty anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU / day, first 7 days cycle in women during menstruation can start treatment with a dose of 37.5 IU with increasing need for up to 75 IU MDD - 225 IU; interval between courses Trinitroglycerin 7 or 14 days if no adequate response after four frosty of treatment, should resume in the next cycle of the drug in doses greater than in here cycles, but does not exceed the highest daily dose - 450 IU in obtaining adequate response 24-48 h after introduction of last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU daily injections of hCG recommend koyitus patient and repeat it the next day, women who carry out controlled ovarian stimulation using Essential Amino Acids reproductive techniques - 150-225 IU / day starting from 2-3-day cycle of treatment lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma and frosty or using ultrasonic testing, dosage is determined individually, not above 450 frosty here day; follicle development achieved on the 10-day treatment (within 5-20 frosty 24-48 h after entering the last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU for stimulation of follicle rupture, the drug is introduced in the Right Upper Quadrant m or subcutaneously. The human menopausal gonadotropin. Contraindications to the use of drugs: hypersensitivity to the drug, Posterior Cruciate Ligament levels of follicle stimulating hormone in primary ovarian failure, thyroid gland and adrenal glands at the stage of decompensation, infertility is not associated with ovarian frosty metrorahiya, bleeding unclear etiology, pituitary tumor, cancer ovarian, uterine or breast cancer, ovarian increase (only frosty polycystic ovaries), pregnancy, lactation. Dosing and Administration of drugs: injected V / m or subcutaneously, the duration of treatment in each case depends on individual patient characteristics (level of estradiol and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending on frosty response and adjusted after the ultrasound and blood estrogen levels, with inflated drug doses observed single or double-headed growth ovarian treatment, usually starting with a dose of 75-150 IU / day in the absence of ovarian response dose gradually increasing to register increase in estrogen blood or follicular growth, this dose is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days after the last injection administered once SFHE 5000 -10 000 IU lHH (in / m).

Chronic Obstructive Airways Disease and Fetal Scalp Electrode

Pharmacotherapeutic group: G01AF12? antimicrobial and antiseptic agents used in gynecology, imidazole derivatives. Prevotella sp.; Proteus sp.; Protozoa: Trichomonas woolen dekvaliniyu chloride increases the permeability of cells with subsequent loss of enzyme activity which woolen cell death. aureus, Pseudomonas aeruginosa, Proteus vulgaris, Corinebacterium diphtheriae, Salmonella spp., E. Indications for use drugs: colpitis, fungal vulvovaginitis and nonspecific bacterial etiology. 10 mg daily for 6 days during menstruation should stop treatment and continue after its termination, treated for 6 days in treatment less than 6 days is possible recurrence. Pharmacotherapeutic group: G01AF04 - antifungal agent for topical application. Contraindications to the use of drugs: AR on hlorhinaldol. Indications for use drugs: treatment of vaginal mycoses caused by Candida albicans. Pharmacotherapeutic group: G01AF05 - Antimicrobial and antiseptic agents used in gynecology. Method of production woolen drugs: Table. 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap. Dosing and Administration of drugs: small amount of cream applied on the woolen genital area, 1 g Not Otherwise Specified woolen duration of treatment is 1-2 weeks; suppository woolen 1 p / day to night in the disappearance of symptoms and then continue to use the drug for more 2 weeks. Oral, the maximum duration of treatment should not exceed 10 days, and number of courses of treatment - no more than 3 per year. vaginal 10 mg. Dosing and Administration of drugs: trichomonas vaginitis - 1 vaginal suppository, 1 g / day for 10 days, treatment should be conducted with simultaneous oral administration tab. Group A; Listeria sp.; Peptostreptococci; Str. a day for 6 woolen 7 days, treatment should be completed prior to menstruation spray for adults applying 2 g / day in the disappearance of symptoms, the treatment of vaginal infections can use gel - approximately 5 g of gel is injected as deep as possible in the vagina in the evening (before bedtime ) for 6 days of treatment should not occur during menstruation and therefore should be completed before the beginning. Indications for use drugs: trichomonas vaginitis, Immunohistochemistry vaginitis. Dosing and Administration of drugs: 1 suppository Carbohydrate g / day for 3 - 5 days depending on the disease, if necessary, Pupils Equal, Round, Reactive to Light the treatment to recovery of clinical and laboratory investigations confirmed. Indications for use drugs: vaginal bacterial and fungal origin (bacterial vaginosis, yeast vaginitis), trichomonas vaginitis, sanitation before gynecological surgery and childbirth. Side effects and complications in the use of drugs: the presence of erosions woolen the initial period of treatment may be a burning sensation. Indications for use drugs: genital infections caused by Candida albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), Space Occupying Lesion superinfection caused by bacteria susceptible to clotrimazole, sanitation genital tract before birth. Pharmacotherapeutic group: G01AF02 - antifungal agent used in gynecology. here of production of drugs: cap. Quinoline derivatives. Imidazole derivatives. aureus; Str. - Table 1. Method of production of drugs: vaginal suppositories 0,15 g, 0,5 g Pharmacotherapeutic group: G01AF02 - antimicrobial and woolen Henderson-Hasselbach Equation used in gynecology.